January 24, 2017 / 2:13 PM / a year ago

BUZZ-Interpace Diagnostics Group Inc: Launches its thyroid test in Canada

** Shares of the provider of molecular diagnostic tests and pathology services rise 17.5 pct to $4.70 premarket

** Says taken initial steps to launch its thyroid product line in Canada

** Says its thyroid test, ThyGenX, has been adopted by Dr. Richard Payne of Montreal, director of the Endocrine Surgery Group at the Canadian Society of Otolaryngology - Head and Neck Surgery

** Physicians typically recommend thyroid surgery when biopsy results are indeterminate

** Molecular testing using ThyGenX and ThyraMir tests has been shown to reduce the rate of unnecessary surgeries in indeterminate cases

** Up to Monday’s close, stock had fallen 9 pct since the start of the year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below